An official website of the United States government
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.
When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.
Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.
Summary: CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. The purpose of this amendment is to establish how the state will pay for the administration of the vaccine and the reimbursement methodology.
Summary: CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. reimburse 100% of Medicare for COVID laboratory testing and COVID laboratory specimen collection.
Summary: Effective October 1, 2020, this amendment provides technical corrections to Page 12c of Attachment 3.1-A, which adds in necessary information that was previously omitted.
Summary: expand the services for which licensed pharmacists are allowed to bill MO HealthNet to include all services within their professional scope of practice.
Summary: Effective December 16, 2018, this amendment brings Missouri into compliance with items contained in the reimbursement requirements for the Covered Outpatient Drug final rule with comment period (CMS-2345-FC) and includes: reimbursement rates for long-term care, specialty drugs, drugs purchased at a nominal price, and physician administered drugs and reimbursement methods that use, among others, the National Average Drug Acquisition Cost (NADAC) for covered outpatient drugs.
Summary: Brings MO into compliance with the professional dispending fee requirement in the Covered Outpatient Drug final rule with comment period (CMS-2345.FC)
